Economic Reporter :
A new pharmaceutical company has been launched in Bangladesh with a promise to make “high quality drugs”.
Health Minister Mohammed Nasim while inaugurating the new pharmaceutical company at a hotel in the city on Saturday. “There are some businessmen who make adulterated drugs,” he said, citing the example of paracetamol poisoning that killed children. He warned against them.
But many doubt government’s capacity to monitor all the drugs available in the market.
“But the drug administration laboratories have the capacity to test maximum 4,500 samples a year that means only 5 percent of the total produce.”
“So the drug control committee has to depend on the company’s own quality assurance,” he said.
He, however, suggested that the “pharma business should be expanded based on the ability of the government’s supervision”. “You have to monitor drugs, there is no other option. So, new companies should be allowed based on your capacity to monitor them, to regulate them.”
“If we had lesser brands, then quality assurance would have been easier.”
The new pharmaceutical company is the concern of National AgriCare Group, which is known for its agri products businesses mostly seeds and pesticides.
The Group’s Managing Director KSM Mostafizur Rahman said based on their successes in agri business, “they now have the confidence to ensure quality medicine to the people”.
He told that their initial investment was about Tk 600 million and they had obtained permission to produce a range of products from anti-ulcerant to anti-asthmatic.
A new pharmaceutical company has been launched in Bangladesh with a promise to make “high quality drugs”.
Health Minister Mohammed Nasim while inaugurating the new pharmaceutical company at a hotel in the city on Saturday. “There are some businessmen who make adulterated drugs,” he said, citing the example of paracetamol poisoning that killed children. He warned against them.
But many doubt government’s capacity to monitor all the drugs available in the market.
“But the drug administration laboratories have the capacity to test maximum 4,500 samples a year that means only 5 percent of the total produce.”
“So the drug control committee has to depend on the company’s own quality assurance,” he said.
He, however, suggested that the “pharma business should be expanded based on the ability of the government’s supervision”. “You have to monitor drugs, there is no other option. So, new companies should be allowed based on your capacity to monitor them, to regulate them.”
“If we had lesser brands, then quality assurance would have been easier.”
The new pharmaceutical company is the concern of National AgriCare Group, which is known for its agri products businesses mostly seeds and pesticides.
The Group’s Managing Director KSM Mostafizur Rahman said based on their successes in agri business, “they now have the confidence to ensure quality medicine to the people”.
He told that their initial investment was about Tk 600 million and they had obtained permission to produce a range of products from anti-ulcerant to anti-asthmatic.
